|
Pons-Fuster E, Gonzalez-Ponce CM, Ros-Martinez S, Fernandez-Avila JJ, Diaz-Carrasco MS, Espuny-Miro A. Real-world clinical outcomes of apalutamide versus abiraterone with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. Int J Clin Pharm. 2025 May 6. doi: 10.1007/s11096-025-01920-4. Online ahead of print. PubMed PMID: 40327314.
AÑO: 2025; IF: 3.2
|
40327314
|
Pons-Fuster E, Lozano-Caballero O, Martin-Balbuena S, Lucas-Rodenas C, Mancebo-Gonzalez A, De Gorostiza-Frias I, Gonzalez-Ponce CM. Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years. Int J Clin Pharm. 2024 Dec;46(6):1317-1326. doi: 10.1007/s11096-024-01758-2. Epub 2024 Jul 11. PubMed PMID: 38990457.
AÑO: 2024; IF: 3.2
|
|
Espanol I, Leal JD, Blanquer M, Garcia-Candel F, Heredia A, Gomez-Espuch J, Gonzalez C, Montserrat J, Diaz-Carrasco MS, Martinez A, Moraleda JM. N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study. Ann Hematol. 2023 Aug;102(8):2069-2075. doi: 10.1007/s00277-023-05248-9. Epub 2023 May 12. PubMed PMID: 37171598; PubMed Central PMCID: PMC10176284.
AÑO: 2023; IF: 3.0
|